First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors
Rodrigo Dienstmann, Ulrik Lassen, Jonathan Cebon, Jayesh Desai, Michael P Brown, Stefan Evers, Fei Su, Weijiang Zhang, Frederic Boisserie, Brian Lestini, Kathleen Schostack, Valerie Meresse, Josep Tabernero
Dyk ned i forskningsemnerne om 'First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors'. Sammen danner de et unikt fingeraftryk.